Objective Tumor Response of Hepatocellular Carcinoma Obtained by Transarterial Radioembolization with Iodine-131-Lipiodol Versus Transarterial Chemoembolization for Patients with and without Portal Venous Thrombosis: A Controlled Interventional Trial.

MLA

Oliveira Ribeiro, Michele Costa de, et al. “Objective Tumor Response of Hepatocellular Carcinoma Obtained by Transarterial Radioembolization with Iodine-131-Lipiodol Versus Transarterial Chemoembolization for Patients with and without Portal Venous Thrombosis: A Controlled Interventional Trial.” Academic Radiology, vol. 31, no. 5, May 2024, pp. 1839–48. EBSCOhost, https://doi.org/10.1016/j.acra.2023.10.029.

APA

Oliveira Ribeiro, M. C. de, Moda, K. A., Alvarez, M., Koga, K. H., Moriguchi, S. M., Carvalho, F. C., Pinheiro, R. S. N., Qi, X., & Romeiro, F. G. (2024). Objective Tumor Response of Hepatocellular Carcinoma Obtained by Transarterial Radioembolization with Iodine-131-Lipiodol Versus Transarterial Chemoembolization for Patients with and without Portal Venous Thrombosis: A Controlled Interventional Trial. Academic Radiology, 31(5), 1839–1848. https://doi.org/10.1016/j.acra.2023.10.029

Chicago

Oliveira Ribeiro, Michele Costa de, Kerolyn Adorne Moda, Matheus Alvarez, Katia Hiromoto Koga, Sônia Marta Moriguchi, Fábio Cardoso Carvalho, Rafael Soares Nunes Pinheiro, Xingshun Qi, and Fernando Gomes Romeiro. 2024. “Objective Tumor Response of Hepatocellular Carcinoma Obtained by Transarterial Radioembolization with Iodine-131-Lipiodol Versus Transarterial Chemoembolization for Patients with and without Portal Venous Thrombosis: A Controlled Interventional Trial.” Academic Radiology 31 (5): 1839–48. doi:10.1016/j.acra.2023.10.029.